Chapter 8021
Chapter 8021
At the same time, Liu Qinghe's action is also a fierce fight for the Chinese medical community.
Most importantly, it is also a good foundation for Zhang Xiaofan to win the next Nobel Prize in medicine.
As for Liu Qinghe, he only needs to explain at the international exchange seminar that all his remarks and research results are based on some theoretical formulas of Zhang Xiaofan.
There is no doubt that this will bring unprecedented sensational effect to the whole world medical community.
After hearing this, Zhang Xiaofan's heart is feeling that there are some feelings of crying and laughing.
Unexpectedly, Liu Qinghe, an old scholar, is still struggling for his Nobel Prize in medicine.
When Liu Qinghe talked to himself about the Nobel Prize in medicine last time, Zhang Xiaofan had already politely refused, showing that he really didn't care about the fame and wealth of the secular world.
However, after seeing Liu Qinghe was so interested in running for the next Nobel Prize in medicine for himself, Zhang Xiaofan did not take it too seriously.
At the same time, he did not refuse Liu Qinghe's kindness to himself, so let Liu Qing and himself watch to prepare.
After Liu Qinghe left Xuanji group, the research and development of new drugs and the press conference were postponed temporarily.
For the most core and key secrets of Xuanji Pharmaceutical Group at present, only Zhang Xiaofan can do as many as he can.
In particular, in the design of Xuanji Pharmaceutical Group, it is not as simple as we can see on the surface that "silver bullet" anticancer drug can be developed today.
Because the key base drug for making the "silver bullet" anticancer drug can only be found in baihuagu, Miao, which is under the jurisdiction of Zhang Xiaofan.
In addition to the problem of the important raw materials of "silver bullet", if we want to successfully produce the "silver bullet" anticancer drug, we still need to practice the truth. The threshold of drug refining technology is at.
In the face of so many technical barriers to "silver bullets" and the monopoly of pharmaceutical raw materials, that is to say, even if it is ten thousand steps backward, Liu Qinghe has really decided to resign.
Unless he packed all the raw materials that could produce silver bullet anticancer drugs from baihuagu, Miao Autonomous Region, and further mastered the medicine refining knowledge of the cultivation world.
Then, Liu Qinghe has the possibility to develop the "silver bullet" anticancer drug.
If not, it would be impossible for Liu Qinghe and the overall development level of the Chinese medical community to imitate the "silver bullet" anticancer drug.
As for the products that Liu Qinghe led in the research and development, compared with ordinary special effects drugs, are responsible for occupying some products in the middle end pharmaceutical market.
If competitive companies can get the prescriptions of these special effects drugs through commercial spies, there is still a great probability that they can imitate and copy them.
However, as long as Xuanji Pharmaceutical Group has mastered the core technology, that is to say, silver bullets, it will be invincible.
As for other Xuanji Pharmaceutical Group's new special drug product launch.
For such a large group as Xuanji Pharmaceutical Group, the role that large enterprises can play is nothing more than icing on the cake, which can further improve the product line of the group.
novelraw